Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke

DOI: 10.1186/s12933-017-0655-y

Keywords: Linagliptin, Dipeptidyl peptidase-4 (DPP-4) inhibitor, Type 2 diabetes mellitus, Acute coronary syndrome, Acute ischemic stroke, Cardiovascular outcome

Full-Text   Cite this paper   Add to My Lib

Abstract:

Flow chart of study subjects selectio

Full-Text